Correlation Between Changchun BCHT and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Changchun BCHT and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Changchun BCHT and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Changchun BCHT Biotechnology and Innovative Medical Management, you can compare the effects of market volatilities on Changchun BCHT and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Changchun BCHT with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Changchun BCHT and Innovative Medical.

Diversification Opportunities for Changchun BCHT and Innovative Medical

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Changchun and Innovative is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Changchun BCHT Biotechnology and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Changchun BCHT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Changchun BCHT Biotechnology are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Changchun BCHT i.e., Changchun BCHT and Innovative Medical go up and down completely randomly.

Pair Corralation between Changchun BCHT and Innovative Medical

Assuming the 90 days trading horizon Changchun BCHT Biotechnology is expected to under-perform the Innovative Medical. But the stock apears to be less risky and, when comparing its historical volatility, Changchun BCHT Biotechnology is 1.94 times less risky than Innovative Medical. The stock trades about -0.14 of its potential returns per unit of risk. The Innovative Medical Management is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  765.00  in Innovative Medical Management on August 28, 2024 and sell it today you would earn a total of  73.00  from holding Innovative Medical Management or generate 9.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Changchun BCHT Biotechnology  vs.  Innovative Medical Management

 Performance 
       Timeline  
Changchun BCHT Biote 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Changchun BCHT Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Changchun BCHT sustained solid returns over the last few months and may actually be approaching a breakup point.
Innovative Medical 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Changchun BCHT and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Changchun BCHT and Innovative Medical

The main advantage of trading using opposite Changchun BCHT and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Changchun BCHT position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Changchun BCHT Biotechnology and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.